Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
Søg efter indhold i Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
A systematic review of bevacizumab efficacy in breast cancer
Iben Kümler
, Ole Grummedal Christiansen, Dorte Lisbet Nielsen
Afdeling for Kræftbehandling HGH
69
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'A systematic review of bevacizumab efficacy in breast cancer'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Adjuvant Setting
60%
Angiogenesis
20%
Angiogenesis Inhibitors
20%
Bevacizumab
100%
Bevacizumab Therapy
20%
Breast Cancer
100%
Breast Cancer Treatment
20%
Cancer Growth
20%
Cancer Invasion
20%
Cancer Metastasis
20%
Cancer Treatment
20%
Computer-based
20%
Literature Search
20%
Metastatic Setting
40%
Molecular Biomarkers
20%
Molecular Mechanism
20%
Overall Survival
20%
Phase I Study
40%
Phase I Trial
40%
Phase II Trial
80%
Prognostic Biomarker
20%
Progression-free Survival
40%
PubMed
20%
Response Rate
60%
Survival Benefit
20%
Time to Progression
20%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
100%
Biological Marker
33%
Breast Cancer
100%
Cancer Growth
16%
Clinical Trial
16%
Malignant Neoplasm
16%
Overall Survival
16%
Phase II Trials
33%
Phase III Trials
33%
Progression Free Survival
33%
Tumor Invasion
16%
Biochemistry, Genetics and Molecular Biology
Angiogenesis
16%
Antiangiogenic Activity
16%
Bevacizumab
100%
Clinical Trial
16%
Overall Survival
16%
Phase II Trials
33%
Phase III Trials
33%
Progression Free Survival
33%
Neuroscience
Angiogenesis
33%
Bevacizumab
100%
Biological Marker
33%
Systematic Review
100%